Dermatology · Lapeer, MI
NPI
1144459942
Since 2009
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1057 Suncrest Dr
Lapeer, MI, 48446
Phone (810) 245-9380
Groups this clinician bills Medicare through
Medicare paid, 2024
$695K
6,170 services
Medicare patients, 2024
860
Average age 74
Drug cost, 2024
$2.1M
5,225 prescriptions
Company payments, 2025
$2,939
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad Zarka was code 17003 (destruction skin lesion), 1,241 times for 174 patients. In total Mohammad Zarka billed 6,170 services in 85 codes, and Medicare paid $695K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,241 | 174 | $4.38 | $5,439 |
| Q4282 Cygnus dual, per square centimeter | Office | 540 | 55 | $630.43 | $340K |
| 99213 Office E&M - Established | Office | 519 | 391 | $59.67 | $31K |
| 99203 Office E&M - New | Office | 458 | 458 | $70.65 | $32K |
| 17000 Destruction Skin Lesion | Office | 288 | 231 | $40.38 | $12K |
| Q4196 Puraply am, per square centimeter | Office | 220 | 14 | $81.34 | $18K |
| 17110 Destruction Skin Lesion | Office | 198 | 153 | $72.23 | $14K |
| 11102 Skin Biopsy | Office | 184 | 166 | $62.39 | $11K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 184 | 53 | $0.72 | $133 |
| 11901 Skin | Office | 136 | 29 | $46.48 | $6,322 |
| 99212 Office E&M - Established | Office | 112 | 104 | $39.34 | $4,406 |
| 99214 Office E&M - Established | Office | 107 | 53 | $80.37 | $8,600 |
| 17311 Mohs Surgery | Office | 88 | 78 | $475.07 | $42K |
| 15275 Skin and Soft Tissue Substitutes | Office | 78 | 50 | $79.01 | $6,163 |
| 11103 Skin Biopsy | Office | 75 | 54 | $36.14 | $2,710 |
By year: 2022 $198K for 2,967 services; 2023 $319K for 4,303 services; 2024 $695K for 6,170 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 24 | 16 | $8.65 | $208 |
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad Zarka prescribed most often to Medicare patients was Triamcinolone Acetonide, with 730 prescriptions and refills. In total Mohammad Zarka wrote 5,225 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 730 | 829 | 476 | $14K |
| Clobetasol Propionate Generic | 687 | 727 | 371 | $19K |
| Ketoconazole Generic | 669 | 758 | 332 | $12K |
| Hydrocortisone Generic | 427 | 583 | 304 | $6,103 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 322 | 333 | 164 | $14K |
| Doxycycline Hyclate Generic | 303 | 329 | 144 | $7,489 |
| Clindamycin Phosphate Generic | 157 | 165 | 79 | $2,335 |
| Imiquimod Generic | 148 | 341 | 107 | $3,770 |
| Ammonium Lactate Generic | 140 | 159 | 98 | $2,611 |
| Mometasone Furoate Generic | 137 | 144 | 70 | $2,389 |
| Hydroxyzine Hcl Generic | 117 | 295 | 67 | $1,234 |
| Methotrexate Methotrexate Sodium | 113 | 272 | 56 | $4,963 |
| Dupixent Pen Dupilumab | 109 | 109 | 12 | $394K |
| Metronidazole Generic | 102 | 110 | 68 | $3,203 |
| Cephalexin Generic | 99 | 99 | 82 | $890 |
Brand drugs: 407 claims; generic drugs: 4,818 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad Zarka $2,939 ($2,939 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novartis Pharmaceuticals Corporation with $536.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 21 | $536 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 17 | $456 |
| Galderma Laboratories, L.P. GALD.SW | 24 | $389 |
| UCB, Inc. UCB.BR | 12 | $276 |
| LEO Pharma Inc. | 17 | $205 |
| Genzyme Corporation SNY | 10 | $182 |
| Abbvie Inc. ABBV | 12 | $181 |
| Lilly USA, LLC LLY | 9 | $148 |
| Incyte Corporation INCY | 3 | $116 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.